How much does a box of Apremilast tablets cost in the latest market price?

Apremilast is an oral small molecule PDE4 inhibitor, mainly suitable for the treatment of moderate to severe plaque psoriasis (Plaque Psoriasis) and psoriatic arthritis. Its mechanism of action is by inhibiting PDE4, reducing the production of pro-inflammatory factors such as TNF-α, IL-17 and IL-23, and increasing the levels of the anti-inflammatory factor IL-10, thereby alleviating the inflammatory response of the skin and joints. This mechanism not only improves skin lesions, but also reduces joint pain and stiffness, which is of great significance to improving the quality of life of patients. The oral advantages of apremilast make it more acceptable for daily treatment, especially for patients who are unwilling or unable to receive long-term injectable biologics.

In the domestic market, Apremilast has been approved for marketing and has been included in the medical insurance catalog. Patients can purchase it directly at hospital pharmacies in various places. Domestic prices vary slightly due to medical insurance reimbursement and regional differences. Generally, the burden on patients is relatively reasonable and the cost of treatment is relatively controllable. In terms of overseas markets, the original drug of Apremilast in the European and North American markets is mainly a European version product with a higher price, usually more than 10,000 yuan per box. At the same time, India, Laos and other countries also have generic drugs of Apremilast on the market. The price is much lower than the original drug, only a few hundred yuan per box, which gives patients more economical choices when choosing drugs.

Apremilast has shown good safety in clinical application. Common side effects are mainly mild to moderate gastrointestinal discomfort, such as diarrhea and nausea, and serious infections or immune-related adverse events are rare. This safety profile and oral convenience make it uniquely advantageous in the long-term management of psoriasis and psoriatic arthritis.

Reference materials:https://go.drugbank.com/drugs/DB05676